{
  "@context": "http://id.who.int/icd/contexts/contextForLinearizationEntity.json",
  "@id": "http://id.who.int/icd/release/11/2024-01/mms/873001259",
  "parent": [
    "http://id.who.int/icd/release/11/2024-01/mms/192130563"
  ],
  "browserUrl": "https://icd.who.int/browse/2024-01/mms/en#873001259",
  "code": "7B02.3",
  "source": "http://id.who.int/icd/entity/873001259",
  "classKind": "category",
  "title": {
    "@language": "en",
    "@value": "Parasomnia disorder due to a medication or substance"
  },
  "definition": {
    "@language": "en",
    "@value": "Parasomnia disorder due to a medication or substance is characterised by abnormal sleep related complex movements, behaviours, emotions, perceptions, dreams, and autonomic nervous system activity that are directly attributable to the effect of a medication or substance."
  },
  "indexTerm": [
    {
      "label": {
        "@language": "en",
        "@value": "Parasomnia disorder due to a medication or substance"
      }
    }
  ]
}